Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2011;38(2):165-7.

Comparison of single versus multiple courses of antenatal betamethasone in patients with threatened preterm labor

Affiliations
  • PMID: 21793281
Clinical Trial

Comparison of single versus multiple courses of antenatal betamethasone in patients with threatened preterm labor

N Bontis et al. Clin Exp Obstet Gynecol. 2011.

Abstract

Purpose of investigation: To compare single versus multiple courses of antenatal betamethasone administration with regards to the morbidity and mortality of preterm neonates.

Methods: One-hundred and twenty-two women with threatened preterm labor were allocated to three different betamethasone schedules: 1) two doses of betamethasone 12 mg, intramuscularly, 24 hours apart (standard treatment) (n = 41); 2) standard treatment plus a third dose of 12 mg after seven days (n = 41); and, 3) standard treatment plus one dose of 12 mg every seven days until delivery (n = 40). Neonatal morbidity and mortality as well as maternal morbidity were evaluated.

Results: Neonatal parameters, such as frequency of respiratory distress syndrome, intraventricular hemorrhage, necrotizing enterocolitis, sepsis and neonatal mortality were not significantly different among the three groups for both singleton and multiple pregnancies. Similarly, maternal parameters were not significantly different among the three groups.

Conclusion: The administration of multiple betamethasone courses in threatened preterm labor is not superior to single courses with regards to neonatal morbidity and mortality, as well as to maternal morbidity.

PubMed Disclaimer

LinkOut - more resources